Showing 1–50 of 97 results

2020 FDA Approvals Ado-trastuzumab-emtansine
+
 Quick View

anti-human

Ado-trastuzumab emtansine Biosimilar – Research Grade [ICH4014]

$1,144.00 – $7,500.00
2020 FDA Approvals Aflibercept
+
 Quick View

anti-human

Aflibercept Biosimilar – Research Grade [ICH4015]

$600.00 – $7,500.00
Western Blot of Atezolizumab Biosimilar ICH4018
+
 Quick View

anti-human

Atezolizumab Biosimilar – Research Grade [ICH4018]

$718.00 – $7,500.00
Western Blot of Adalimumab Biosimilar ICH40012020 FDA Approvals Adalimumab
+
 Quick View

anti-human

Adalimumab Biosimilar – Research Grade

$718.00 – $7,500.00
+
 Quick View

anti-human

Blinatumomab Biosimilar – Research Grade [ICH5025]

$300.00 – $4,000.00
+
 Quick View

anti-human

Theralizumab Biosimilar – Research Grade [ICH5023]

$300.00 – $7,500.00
2020 FDA Approvals for Ranibizumab
+
 Quick View

anti-human

Ranibizumab Biosimilar – Research Grade [ICH4031]

$300.00 – $7,500.00
Western Blot of Pembrolizumab Biosimilar ICH40292020 FDA Approvals for Pembrolizumab
+
 Quick View

anti-human

Pembrolizumab Biosimilar – Research Grade [ICH4029]

$718.00 – $7,500.00
2020 FDA Approvals Ipilimumab
+
 Quick View

anti-human

Ipilimumab Biosimilar – Research Grade [ICH4025]

$718.00 – $7,500.00
2020 FDA Approvals for Rituximab
+
 Quick View

anti-human

Rituximab Biosimilar – Research Grade [ICH4011]

$718.00 – $7,500.00
2020 FDA Approvals for Pertuzumab
+
 Quick View

anti-human

Pertuzumab Biosimilar – Research Grade [ICH4030]

$718.00 – $7,500.00
Natalizumab biosimilar
+
 Quick View

anti-human

Natalizumab Biosimilar – Research Grade [ICH4037]

$704.00 – $7,500.00
+
 Quick View

anti-human

Etanercept Biosimilar – Research Grade [ICH4022]

$718.00 – $7,500.00
2020 FDA Approvals Bevacizumab
+
 Quick View

anti-human

Bevacizumab Biosimilar – Research Grade [ICH4003]

$718.00 – $7,500.00
+
 Quick View

anti-human

Urelumab Biosimilar – Research Grade [ICH5015]

$300.00 – $7,500.00
2020 FDA Approvals for Trastuzumab
+
 Quick View

anti-human

Trastuzumab Biosimilar – Research Grade [ICH4013]

$718.00 – $7,500.00
2020 FDA Approvals for Secukinumab
+
 Quick View

anti-human

Secukinumab Biosimilar – Research Grade [ICH4033]

$300.00 – $7,500.00
+
 Quick View

anti-human

Panitumumab Biosimilar – Research Grade [ICH4028]

$718.00 – $7,500.00
2020 FDA Approvals for Nivolumab
+
 Quick View

anti-human

Nivolumab Biosimilar – Research Grade [ICH4009]

$718.00 – $7,500.00
2020 FDA Approvals Denosumab
+
 Quick View

anti-human

Denosumab Biosimilar – Research Grade [ICH4019]

$718.00 – $7,500.00
Western Blot of Avelumab Biosimilar ICH40172020 FDA Approvals Avelumab
+
 Quick View

anti-human

Avelumab Biosimilar – Research Grade [ICH4017]

$718.00 – $7,500.00
+
 Quick View

anti-human

Mosunetuzumab Biosimilar – Research Grade [ICH5026]

$300.00 – $9,000.00
+
 Quick View

anti-human

Varlilumab Biosimilar – Research Grade [ICH5022]

$300.00 – $7,500.00
2020 FDA Approvals for Ustekinumab
+
 Quick View

anti-human

Ustekinumab Biosimilar – Research Grade [ICH4034]

$718.00 – $7,500.00
2020 FDA Approvals for Ofatumumab
+
 Quick View

anti-human

Ofatumumab Biosimilar – Research Grade [ICH4027]

$718.00 – $7,500.00
2020 FDA Approvals Eculizumab
+
 Quick View

anti-human

Eculizumab Biosimilar – Research Grade [ICH4005]

$300.00 – $7,500.00
2020 FDA Approvals Cetuximab
+
 Quick View

anti-human

Cetuximab Biosimilar – Research Grade [ICH4004]

$718.00 – $7,500.00
2020 FDA Approvals Alirocumab
+
 Quick View

anti-human

Alirocumab Biosimilar – Research Grade [ICH4016]

$718.00 – $15,000.00
+
 Quick View

Antibodies

Caplacizumab Biosimilar – Research Grade

$300.00 – $7,500.00
+
 Quick View

Antibodies

Belimumab Biosimilar – Research Grade

$300.00 – $7,500.00
+
 Quick View

anti-human

Glofitamab Biosimilar – Research Grade [ICH5019]

$300.00 – $9,000.00
+
 Quick View

anti-human

Monalizumab Biosimilar – Research Grade [ICH5017]

$300.00 – $7,500.00
+
 Quick View

anti-human

Utomilumab Biosimilar – Research Grade [ICH5014]

$300.00 – $7,500.00
2020 FDA Approvals for Vedolizumab
+
 Quick View

anti-human

Vedolizumab Biosimilar – Research Grade [ICH4035]

$718.00 – $7,500.00
2020 FDA Approvals for Tocilizumab
+
 Quick View

anti-human

Tocilizumab Biosimilar – Research Grade [ICH4012]

$936.00 – $7,500.00
+
 Quick View

Antibodies

Penpulimab Biosimilar – Research Grade

$300.00 – $7,500.00
+
 Quick View

Antibodies

Ponezumab Biosimilar – Research Grade

$300.00 – $7,500.00
+
 Quick View

Antibodies

Rilotumumab Biosimilar – Research Grade

$300.00 – $7,500.00
+
 Quick View

Antibodies

Robatumumab Biosimilar – Research Grade

$300.00 – $7,500.00
+
 Quick View

Antibodies

Romosozumab Biosimilar – Research Grade

$300.00 – $7,500.00
+
 Quick View

Antibodies

Sarilumab Biosimilar – Research Grade

$300.00 – $7,500.00
+
 Quick View

Antibodies

Satralizumab Biosimilar – Research Grade

$300.00 – $7,500.00
+
 Quick View

Antibodies

Sifalimumab Biosimilar – Research Grade

$300.00 – $7,500.00
+
 Quick View

Antibodies

Siltuximab Biosimilar – Research Grade

$300.00 – $7,500.00
+
 Quick View

Antibodies

Tabalumab Biosimilar – Research Grade

$300.00 – $7,500.00
+
 Quick View

Antibodies

Tanezumab Biosimilar – Research Grade

$300.00 – $7,500.00
+
 Quick View

Antibodies

Teplizumab Biosimilar – Research Grade

$300.00 – $7,500.00
+
 Quick View

Antibodies

Tovetumab Biosimilar – Research Grade

$300.00 – $7,500.00
+
 Quick View

Antibodies

Veltuzumab Biosimilar – Research Grade

$300.00 – $7,500.00
+
 Quick View

Antibodies

Ieramilimab Biosimilar – Research Grade

$300.00 – $7,500.00